Hyperhomocysteinemia due to levodopa treatment as a risk factor for osteoporosis in patients with Parkinson's disease.
Lee SH, Kim MJ, Kim BJ, Kim SR, Chun S, Kim HK, Ryu JS, Kim GS, Lee MC, Chung SJ, Koh JM.
Lee SH, et al. Among authors: kim sr, kim hk, kim bj, kim gs, kim mj.
Calcif Tissue Int. 2010 Feb;86(2):132-41. doi: 10.1007/s00223-009-9327-6. Epub 2010 Jan 5.
Calcif Tissue Int. 2010.
PMID: 20049422